Affordable At-Home Molecular Test for COVID-19, Flu-A, Flu-B & RSV Moving Closer
The award through the NIH’s RADx Tech program, will support Domus Diagnostics’ at-home molecular test for clinical trial readiness.
Read MorePosted by Chris Wolski | May 25, 2023 | Molecular Diagnostics |
The award through the NIH’s RADx Tech program, will support Domus Diagnostics’ at-home molecular test for clinical trial readiness.
Read MorePosted by Chris Wolski | May 9, 2023 | Flu & Respiratory Infections, Molecular Diagnostic Analyzers, POC Instruments |
Cue Health announced that it has made a De Novo submission to the FDA for full clearance of the Cue RSV Molecular Test.
Read MorePosted by Melanie Hamilton-Basich | May 4, 2023 | Point-of-Care |
New findings suggest offering genetic testing at the point of care along with a digital cancer risk assessment could increase uptake.
Read MorePosted by Melanie Hamilton-Basich | May 2, 2023 | Company News |
Uh-Oh Labs is rebranding to Scout, reflecting the company’s expanded mission and focus on providing accurate health data and fast results.
Read MorePosted by Chris Wolski | Apr 21, 2023 | Diabetes & Metabolic Diseases, Lab Automation |
Digital Diagnostics, an artificial intelligence diagnostic health care company, has expanded into lab settings in the Southeastern U.S.
Read More